Reaction
Cardiovascular Insufficiency reporting signals
As of the last recalculation, Cardiovascular Insufficiency appears in 1,601 FAERS reports alongside 36 co-occurring drug terms. The strongest observed disproportionality signal is CALCIUM GLUCONATE (PRR 29.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Calcium Gluconate | 27 | 29.6 | 29.7 |
| Norepinephrine Bitartrate | 23 | 21.1 | 21.1 |
| Dextrose | 20 | 20.0 | 20.0 |
| Dextrose Monohydrate | 20 | 19.7 | 19.7 |
| Midazolam Hydrochloride | 38 | 18.8 | 18.8 |
| Norepinephrine | 15 | 18.4 | 18.4 |
| Itraconazole | 16 | 18.0 | 18.0 |
| Sevoflurane | 11 | 17.3 | 17.3 |
| Midazolam | 32 | 16.8 | 16.8 |
| Eplerenone | 16 | 16.4 | 16.4 |
| Indapamide | 19 | 13.9 | 13.9 |
| Propofol | 38 | 13.8 | 13.8 |
| Cefazolin | 9 | 12.9 | 12.9 |
| Meropenem | 31 | 12.8 | 12.8 |
| Cefuroxime | 11 | 12.6 | 12.6 |
| Voriconazole Injection | 20 | 12.1 | 12.1 |
| Cefazolin Sodium | 11 | 11.9 | 12.0 |
| Nebivolol | 14 | 11.5 | 11.5 |
| Acetylcysteine | 8 | 11.1 | 11.1 |
| Dronedarone | 8 | 10.2 | 10.2 |
| Torsemide | 25 | 10.0 | 10.0 |
| Voriconazole | 22 | 9.5 | 9.5 |
| Heparin Sodium | 10 | 9.5 | 9.5 |
| Amiodarone Hydrochloride | 8 | 9.3 | 9.3 |
| Timolol | 8 | 8.6 | 8.7 |
| Buspirone Hydrochloride | 7 | 8.3 | 8.3 |
| Febuxostat Tablets 40 Mg | 6 | 7.7 | 7.7 |
| Febuxostat Tablets 80 Mg | 6 | 7.7 | 7.7 |
| Nilotinib | 15 | 6.7 | 6.7 |
| Rocuronium Bromide | 6 | 6.6 | 6.6 |
| Brentuximab Vedotin | 5 | 6.4 | 6.4 |
| Ocrelizumab | 28 | 6.0 | 6.0 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 14 | 5.9 | 5.9 |
| Sacubitril And Valsartan | 44 | 5.0 | 5.0 |
| Paliperidone | 7 | 3.9 | 3.9 |
| Remdesivir | 3 | 2.9 | 2.9 |